Tracer library / [111In]In-exendin
[111In]In-exendin
Also written as [111In]In-exendin
- Radionuclide
- In-111
- Modality
- —
- Production route
- —
- Stage
- —
- Syntheses indexed
- 2
What it is
- Compound class
- Exendin peptide analogue
- Target / mechanism
- —
- Clinical application
- —
- Theranostic pair
- —
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| — | — | — | — | >95% | [Lys40-DTPA]-exendin-3 Peptide Specialty Laboratories | 21170526 2011 Eur J Nucl Med Mol Imaging |
| Manual synthesis | — | — | — | >95% | [Lys40(Ahx-DTPA)NH2]-exendin-3 Peptide Specialty Laboratories | 19722105 2010 Eur J Nucl Med Mol Imaging The peptide was labelled with 111InCl3 in a 0.1 M 2-(N-morpholino)ethanesulfonic acid (MES) buffer, pH 5.5. A mixture of 19 MBq of 111In and 1 µg of exendin was incubated for 30 min at room temperature. |
Precursor
- Common precursor
- —
- Suppliers seen in the literature
- —
- Cited suppliers in indexed syntheses
- Peptide Specialty Laboratories
- Typical final purification
- —
Need this precursor?We can point you to suppliers for [111In]In-exendin, or handle the enquiry for you.
Get in touchNotes
Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 19722105, 21170526.